These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 10856535)

  • 1. Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia.
    Raal FJ; Pappu AS; Illingworth DR; Pilcher GJ; Marais AD; Firth JC; Kotze MJ; Heinonen TM; Black DM
    Atherosclerosis; 2000 Jun; 150(2):421-8. PubMed ID: 10856535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR
    Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.
    Yamamoto A; Harada-Shiba M; Kawaguchi A; Oi K; Kubo H; Sakai S; Mikami Y; Imai T; Ito T; Kato H; Endo M; Sato I; Suzuki Y; Hori H
    Atherosclerosis; 2000 Nov; 153(1):89-98. PubMed ID: 11058703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased production of low density lipoprotein by atorvastatin after apheresis in homozygous familial hypercholesterolemia.
    Marais AD; Naoumova RP; Firth JC; Penny C; Neuwirth CK; Thompson GR
    J Lipid Res; 1997 Oct; 38(10):2071-8. PubMed ID: 9374129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia.
    O'Neill FH; Patel DD; Knight BL; Neuwirth CK; Bourbon M; Soutar AK; Taylor GW; Thompson GR; Naoumova RP
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):832-7. PubMed ID: 11348882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin.
    Naoumova RP; Dunn S; Rallidis L; Abu-Muhana O; Neuwirth C; Rendell NB; Taylor GW; Thompson GR
    J Lipid Res; 1997 Jul; 38(7):1496-500. PubMed ID: 9254075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia.
    Goldammer A; Wiltschnig S; Heinz G; Jansen M; Stulnig T; Hörl WH; Derfler K
    Metabolism; 2002 Aug; 51(8):976-80. PubMed ID: 12145769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.
    Castaño G; Mas R; Fernández L; Illnait J; Mesa M; Alvarez E; Lezcay M
    Drugs Aging; 2003; 20(2):153-63. PubMed ID: 12534315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
    QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia.
    Marais AD; Raal FJ; Stein EA; Rader DJ; Blasetto J; Palmer M; Wilpshaar W
    Atherosclerosis; 2008 Mar; 197(1):400-6. PubMed ID: 17727860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis.
    Geiss HC; Parhofer KG; Schwandt P
    J Intern Med; 1999 Jan; 245(1):47-55. PubMed ID: 10095816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemia.
    Sposito AC; Gonbert S; Bruckert E; Atassi M; Beucler I; Amsellem S; Khallouf O; Benlian P; Turpin G
    Arterioscler Thromb Vasc Biol; 2003 Nov; 23(11):2078-82. PubMed ID: 14512370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
    LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
    N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia.
    Gandelman K; Glue P; Laskey R; Jones J; LaBadie R; Ose L
    Pediatr Cardiol; 2011 Apr; 32(4):433-41. PubMed ID: 21259004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of statins in hypertriglyceridemia.
    Stein EA; Lane M; Laskarzewski P
    Am J Cardiol; 1998 Feb; 81(4A):66B-69B. PubMed ID: 9526817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia.
    Gagné C; Gaudet D; Bruckert E;
    Circulation; 2002 May; 105(21):2469-75. PubMed ID: 12034651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia.
    Hagemenas FC; Pappu AS; Illingworth DR
    Eur J Clin Invest; 1990 Apr; 20(2):150-7. PubMed ID: 2112479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia.
    Raal FJ; Pilcher GJ; Veller MG; Kotze MJ; Joffe BI
    Am J Cardiol; 1999 Dec; 84(11):1344-6, A7. PubMed ID: 10614803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug clinics. Drug of the month. Atorvastatin (Lipitor)].
    Scheen AJ
    Rev Med Liege; 1998 Jun; 53(6):374-7. PubMed ID: 9713220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.